With companies including AstraZeneca, Pfizer and Revolution Medicines clamoring to get in on Summit Therapeutics’ ...
TECH's Q1 earnings are on deck, with revenues and EPS growth expected as investors weigh segment performance and the pending $11.3 billion acquisition.
Hear from cytometry expert Derek Davies and spectral flow cytometry pioneer Prof. J. Paul Robinson on how flow cytometry has ...
Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, ...
Blue Matter, a world-class consulting firm serving the life sciences industry, today announced the acquisition of Cognite, a leading global healthcare communications agency that helps pharmaceutical ...
Illinois Tool Works Q3 highlights: mixed segment results, EPS beat, and raised 2026 profit guidance. Read here for a detailed ...
Tula Technology, Inc., a leader in propulsion efficiency and developer of Dynamic Motor Drive® (DMD), today announced that it ...
Explore how integrated scenario modeling helps pharma leaders navigate pricing uncertainty and the complexity of global ...
Etiome, Cellarity and Empress Therapeutics are being combined into one new AI-aided drugmaker claiming to possess the ability ...
Draws 'Men's Fitness' Spotlight As Unbuzzd Trial Shows Early Promise. Earlier this month,“Men's Fitness,” reviewed t ...
Strategic consulting firm Blue Matter is boosting its communications digs with the acquisition of global healthcare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results